Inhibition of Rad51 sensitizes breast cancer cells with wild-type PTEN to olaparib-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Inhibition of Rad51 sensitizes breast cancer cells with wild-type PTEN to olaparib

Published:2017-10 Issue: Volume:94 Page:165-168
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Zhao Qian,Guan Jiawei,Zhang Zhiwei,Lv Jian,Wang Yulu,Liu Likun,Zhou Qi,Mao Weifeng

Funder

Chinese National Scientific Foundation

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference21 articles.

1. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer;Li;Science,1997

2. The functions and regulation of the PTEN tumour suppressor;Song;Nat. Rev. Mol. Cell Biol.,2012

3. Essential role for nuclear PTEN in maintaining chromosomal integrity;Shen;Cell,2007

4. PTEN interacts with histone H1 and controls chromatin condensation;Chen;Cell Rep.,2014

5. PTEN loss compromises homologous recombination repair in astrocytes: implications for glioblastoma therapy with temozolomide or poly(ADP-ribose) polymerase inhibitors;McEllin;Cancer Res.,2010

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Roles of long noncoding RNA in triple‐negative breast cancer;Cancer Medicine;2023-10

2. DNA repair pathways in breast cancer: from mechanisms to clinical applications;Breast Cancer Research and Treatment;2023-06-08

3. Synergistic effect of PARP inhibitor and BRD4 inhibitor in multiple models of ovarian cancer;Journal of Cellular and Molecular Medicine;2023-02-08

4. Inhibition of BAD-Ser99 phosphorylation synergizes with PARP inhibition to ablate PTEN-deficient endometrial carcinoma;Cell Death & Disease;2022-06-20

5. High RAD51 gene expression is associated with aggressive biology and with poor survival in breast cancer;Breast Cancer Research and Treatment;2022-03-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3